These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3488177)

  • 21. Plasmid-mediated beta-lactamase (TEM-7) involved in resistance to ceftazidime and aztreonam.
    Gutmann L; Kitzis MD; Billot-Klein D; Goldstein F; Tran Van Nhieu G; Lu T; Carlet J; Collatz E; Williamson R
    Rev Infect Dis; 1988; 10(4):860-6. PubMed ID: 3055178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aztreonam-clavulanic acid synergy does not mean extended-spectrum beta-lactamase in Stenotrophomonas maltophilia.
    Muñoz Bellido JL; García-Rodriguez JA
    J Antimicrob Chemother; 1998 Apr; 41(4):493-4. PubMed ID: 9598782
    [No Abstract]   [Full Text] [Related]  

  • 23. Inhibitory activity of avibactam against selected β-lactamases expressed in an isogenic Escherichia coli strain.
    Giani T; Cannatelli A; Di Pilato V; Testa R; Nichols WW; Rossolini GM
    Diagn Microbiol Infect Dis; 2016 Sep; 86(1):83-5. PubMed ID: 27394638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In-vitro evaluation of carumonam (Ro 17-2301).
    Stobberingh EE; Houben AW; van Boven CP
    J Antimicrob Chemother; 1986 Sep; 18(3):345-50. PubMed ID: 3490467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of Ro 17-2301 (AMA-1080) with beta-lactamases.
    Then RL
    Chemotherapy; 1984; 30(6):398-407. PubMed ID: 6335074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Type I beta-lactamases of gram-negative bacteria: interactions with beta-lactam antibiotics.
    Sanders CC; Sanders WE
    J Infect Dis; 1986 Nov; 154(5):792-800. PubMed ID: 3490520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Group 1 beta-lactamases of Aeromonas caviae and their resistance to beta-lactam antibiotics.
    Lupiola-Gómez PA; González-Lama Z; Tejedor-Junco MT; González-Martín M; Martín-Barrasa JL
    Can J Microbiol; 2003 Mar; 49(3):207-15. PubMed ID: 12795407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative in vitro activity of carumonam with gentamicin and other beta-lactam antimicrobials: a multicentric study.
    Martín-Luengo F; Baquero F; Cisterna R; García de Lomas J; García-Rodriguez J; Gobernado M; Gómez Lus R; Perea E; Piedrola G; Roy C
    Chemioterapia; 1987 Jun; 6(2 Suppl):115-6. PubMed ID: 3334551
    [No Abstract]   [Full Text] [Related]  

  • 29. Overproduced beta-lactamase and the outer-membrane barrier as resistance factors in Serratia marcescens highly resistant to beta-lactamase-stable beta-lactam antibiotics.
    Hechler U; van den Weghe M; Martin HH; Frère JM
    J Gen Microbiol; 1989 May; 135(5):1275-90. PubMed ID: 2695600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-lactamase stability of temocillin.
    Edmondson RA; Reading C
    Drugs; 1985; 29 Suppl 5():64-6. PubMed ID: 3875474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Common Flanking Region in Promiscuous Plasmids Encoding blaNDM-1 in Klebsiella pneumoniae Isolated in Singapore.
    Chen YT; Siu LK; Tsai YK; Lin FM; Koh TH; Chen JH
    Microb Drug Resist; 2016 Mar; 22(2):109-14. PubMed ID: 26308279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Active-Site Protonation States in an Acyl-Enzyme Intermediate of a Class A β-Lactamase with a Monobactam Substrate.
    Vandavasi VG; Langan PS; Weiss KL; Parks JM; Cooper JB; Ginell SL; Coates L
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27795378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro susceptibility of characterized β-lactamase-producing Gram-negative bacteria isolated in Japan to ceftazidime-, ceftaroline-, and aztreonam-avibactam combinations.
    Yoshizumi A; Ishii Y; Aoki K; Testa R; Nichols WW; Tateda K
    J Infect Chemother; 2015 Feb; 21(2):148-51. PubMed ID: 25444674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Beta-lactamases in laboratory and their role in resistance Part I.: Evolution of bacterial resistance mediated by beta-lactamases].
    Bedenić B
    Lijec Vjesn; 2004; 126(11-12):314-24. PubMed ID: 16082890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization and amino acid sequence of the OXY-2 group beta-lactamase of pI 5.7 isolated from aztreonam-resistant Klebsiella oxytoca strain HB60.
    Farzaneh S; Péduzzi J; Sofer L; Reynaud A; Barthélémy M; Labia R
    J Antimicrob Chemother; 1997 Dec; 40(6):789-95. PubMed ID: 9462429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activities of ceftazidime, ceftaroline, and aztreonam alone and combined with avibactam against isogenic Escherichia coli strains expressing selected single β-lactamases.
    Papp-Wallace KM; Bajaksouzian S; Abdelhamed AM; Foster AN; Winkler ML; Gatta JA; Nichols WW; Testa R; Bonomo RA; Jacobs MR
    Diagn Microbiol Infect Dis; 2015 May; 82(1):65-9. PubMed ID: 25737290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In-vitro antibacterial activity of AMA-1080.
    Matsuda K; Hamana Y; Inoue M; Mitsuhashi S
    J Antimicrob Chemother; 1985 Nov; 16(5):539-47. PubMed ID: 3878360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase.
    Weston GS; Blázquez J; Baquero F; Shoichet BK
    J Med Chem; 1998 Nov; 41(23):4577-86. PubMed ID: 9804697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism of acyl-enzyme complex formation from the Henry-Michaelis complex of class C β-lactamases with β-lactam antibiotics.
    Tripathi R; Nair NN
    J Am Chem Soc; 2013 Oct; 135(39):14679-90. PubMed ID: 24010547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Purification of beta-lactamases and enzyme kinetic studies on aztreonam.
    Zhao XJ; Li JT
    Chin Med J (Engl); 1992 May; 105(5):424-9. PubMed ID: 1499375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.